Zhe Jiang Dayang Biotech Group Balance Sheet Health
Financial Health criteria checks 5/6
Zhe Jiang Dayang Biotech Group has a total shareholder equity of CN¥1.0B and total debt of CN¥346.8M, which brings its debt-to-equity ratio to 34.6%. Its total assets and total liabilities are CN¥1.6B and CN¥590.1M respectively. Zhe Jiang Dayang Biotech Group's EBIT is CN¥45.0M making its interest coverage ratio -10.3. It has cash and short-term investments of CN¥468.5M.
Key information
34.6%
Debt to equity ratio
CN¥346.83m
Debt
| Interest coverage ratio | -10.3x |
| Cash | CN¥468.49m |
| Equity | CN¥1.00b |
| Total liabilities | CN¥590.10m |
| Total assets | CN¥1.59b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 003017's short term assets (CN¥751.4M) exceed its short term liabilities (CN¥479.3M).
Long Term Liabilities: 003017's short term assets (CN¥751.4M) exceed its long term liabilities (CN¥110.8M).
Debt to Equity History and Analysis
Debt Level: 003017 has more cash than its total debt.
Reducing Debt: 003017's debt to equity ratio has increased from 5.3% to 34.6% over the past 5 years.
Debt Coverage: 003017's debt is well covered by operating cash flow (29.3%).
Interest Coverage: 003017 earns more interest than it pays, so coverage of interest payments is not a concern.